FRESENIUS MEDICAL CARE AG Gains Losses On Exchange Differences On Translation Before Tax
FRESENIUS MEDICAL CARE AG (FMCQF) reported Gains Losses On Exchange Differences On Translation Before Tax of EUR 524.40 million for the 3-month period ending 2019-09-30, per its 6-K filed 2019-10-31.
Discontinued › Income Statement › Other Income
ifrs-full:GainsLossesOnExchangeDifferencesOnTranslationBeforeTax · last filed 2019-10-31
- FRESENIUS MEDICAL CARE AG gains losses on exchange differences on translation before tax for the quarter ending 2019-09-30 was 524.40M EUR, a 1319.36% increase year-over-year.
- FRESENIUS MEDICAL CARE AG gains losses on exchange differences on translation before tax for the quarter ending 2019-06-30 was -139.82M EUR, a 135.46% decline year-over-year.
- FRESENIUS MEDICAL CARE AG gains losses on exchange differences on translation before tax for the quarter ending 2019-03-31 was 269.74M EUR.
- FRESENIUS MEDICAL CARE AG gains losses on exchange differences on translation before tax for the quarter ending 2018-12-31 was 161.13M EUR.
| Period end | Gains Losses On Exchange Differences On Translation Before Tax 3 month | Gains Losses On Exchange Differences On Translation Before Tax 3 month as first filed | Gains Losses On Exchange Differences On Translation Before Tax 6 month | Gains Losses On Exchange Differences On Translation Before Tax 9 month | Gains Losses On Exchange Differences On Translation Before Tax 12 month |
|---|---|---|---|---|---|
| 2019-09-30 | 524.40M EUR 6-K · filed 2019-10-31 | 384.58M EUR derived: sum of 2 quarters · filed 2019-10-31 | 654.32M EUR 6-K · filed 2019-10-31 | 815.45M EUR derived: sum of 4 quarters · filed 2019-10-31 | |
| 2019-06-30 | -139.82M EUR 6-K · filed 2019-07-30 | 129.92M EUR 6-K · filed 2019-07-30 | 291.05M EUR derived: sum of 3 quarters · filed 2019-07-30 | 328.00M EUR derived: sum of 4 quarters · filed 2019-10-31 | |
| 2019-03-31 | 269.74M EUR 6-K · filed 2019-05-02 | 430.87M EUR derived: sum of 2 quarters · filed 2019-05-02 | 467.81M EUR derived: sum of 3 quarters · filed 2019-10-31 | 862.10M EUR derived: sum of 4 quarters · filed 2019-10-31 | |
| 2018-12-31 | 161.13M EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-02-20 | 198.07M EUR derived: sum of 2 quarters · filed 2019-10-31 | 592.36M EUR derived: sum of 3 quarters · filed 2019-10-31 | 327.32M EUR 20-F · filed 2019-02-20 | |
| 2018-09-30 | 36.95M EUR 6-K · filed 2019-10-31 | 431.23M EUR derived: sum of 2 quarters · filed 2019-10-31 | 166.19M EUR 6-K · filed 2019-10-31 | -21.95M EUR derived: sum of 4 quarters · filed 2019-10-31 | |
| 2018-06-30 | 394.29M EUR 6-K · filed 2019-07-30 | 392.90M EUR 6-K · filed 2018-08-01 | 129.25M EUR 6-K · filed 2019-07-30 | -58.89M EUR derived: sum of 3 quarters · filed 2019-07-30 | -393.38M EUR derived: sum of 4 quarters · filed 2019-07-30 |
| 2018-03-31 | -265.04M EUR 6-K · filed 2019-05-02 | -263.65M EUR 6-K · filed 2018-05-03 | -453.18M EUR derived: sum of 2 quarters · filed 2019-05-02 | -787.66M EUR derived: sum of 3 quarters · filed 2019-05-02 | -1.49B EUR derived: sum of 4 quarters · filed 2019-05-02 |
| 2017-12-31 | -188.14M EUR derived: 20-F 12 month − 6-K 9 month · filed 2019-02-20 | -522.62M EUR derived: sum of 2 quarters · filed 2019-02-20 | -1.22B EUR derived: sum of 3 quarters · filed 2019-02-20 | -1.28B EUR 20-F · filed 2019-02-20 | |
| 2017-09-30 | -334.49M EUR 6-K · filed 2018-10-30 | -1.03B EUR derived: sum of 2 quarters · filed 2018-10-30 | -1.10B EUR 6-K · filed 2018-10-30 | ||
| 2017-06-30 | -700.18M EUR 6-K · filed 2018-08-01 | -761.55M EUR 6-K · filed 2018-08-01 | |||
| 2017-03-31 | -61.37M EUR 6-K · filed 2018-05-03 | ||||
| 2016-12-31 | 368.43M EUR 20-F · filed 2019-02-20 | ||||
| 2015-12-31 | 674.73M EUR 20-F · filed 2018-02-27 |